| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002022808A3 Cripto mutant and uses thereof |
| 01/16/2003 | WO2001093913A3 T cell receptor fusions and conjugates and methods of use thereof |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013148 Genration of preferential fusion polypeptides; obtain amino acid sequences, immobilize on solid supports, react, recover fusion polypeptide |
| 01/16/2003 | US20030013130 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/15/2003 | EP1274852A2 Targeted vaccine delivery systems |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506365 Fibrin/fibrinogen binding conjugate |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002143A1 A novel engineered superantigen for human therapy |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002048189A3 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | US20030008820 Methods and products related to FGF dimerization |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008344 T1R taste receptors and genes encoding same |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1272647A1 Multivalent antibodies and uses therefor |
| 01/08/2003 | EP1272641A2 Serine-threonine kinase |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
| 01/08/2003 | EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 01/08/2003 | EP1272513A2 Neurogenic compositions and methods |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
| 01/07/2003 | US6504082 Ecdysone receptors and methods for their use |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000732A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2446218A1 Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| 01/02/2003 | US20030004323 Novel antigen constructs useful in the detection and differention of antibodies to hiv |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030003542 ACPL polypeptides |
| 01/02/2003 | US20030003535 Single chain class I major histo-compatibility complexes |
| 01/02/2003 | US20030003449 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 01/02/2003 | US20030003098 Treating graft with molecule which binds to co-stimulatory protein of antigen-presenting cells |
| 01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
| 01/02/2003 | EP1270590A1 Human CD24-like protein and nucleic acids encoding it |
| 01/02/2003 | EP1269199A2 Methods involving induced dimerisation by cellular components |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
| 01/02/2003 | EP1268816A2 Calcium-binding regulatory subunit |
| 01/02/2003 | EP1268803A2 Bi-functional cancer treatment agents |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268799A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268796A1 Identification of human gaba transporter |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |